CLEARWATER, Fla., Nov. 30, 2016 -- Tech Data Corporation (Nasdaq:TECD) today announced the appointment of Bridgette Heller to the company’s Board of Directors, effective immediately. Heller will serve as an independent director and will also serve as a member of the Audit Committee and Governance and Nominating Committee.
“Tech Data’s Board of Directors is very pleased to welcome Bridgette,” said Steve Raymund, chairman of the Board of Tech Data. “Her significant leadership experience at large global companies will enable her to provide valuable insight related to international operations, finance, management, and risk. We look forward to her guidance to help further the growth and success of Tech Data.”
Heller has served as executive vice president, Early Life Nutrition, and a member of the Executive Committee for Danone since July 2016. From 2010 to 2015, she served as executive vice president of Merck & Co., Inc. and president of Merck Consumer Care. Prior to joining Merck, Heller was president of Johnson & Johnson’s Global Baby Business Unit from 2007 to 2010 and president of their Global Baby, Kids, and Wound Care business from 2005 to 2007. Previously, she was the founder and managing partner of Heller Associates from 2002 to 2005 and served as Chief Executive Officer of Chung’s Foods 2003 to 2004. Heller was with Kraft Foods from 1985 to 2002, ultimately serving as executive vice president and general manager for the North American Coffee Portfolio.
Heller served on the Board of Directors for The ADT Corporation from 2012 until May 2016, when it was acquired by funds managed by affiliates of Apollo Global Management, LLC. She also served as a director of PCA International, Inc., as well as on the National Board of Directors of Girls Incorporated for twelve years, including four as chair. Heller holds an MBA from Northwestern University’s Kellogg Graduate School of Management and received her B.A. in Economics and Computer Studies from Northwestern University.
About Tech Data
Tech Data Corporation is one of the world’s largest wholesale distributors of technology products, services and solutions. Its advanced logistics capabilities and value added services enable 105,000 resellers to efficiently and cost effectively support the diverse technology needs of end users in more than 100 countries. Tech Data generated $26.4 billion in net sales for the fiscal year ended January 31, 2016. It is ranked No. 108 on the Fortune 500® and one of Fortune’s “World’s Most Admired Companies.” To learn more, visit www.techdata.com, or follow us on Facebook and Twitter.
Contacts Investors/Analysts: Arleen Quinones Vice President, Investor Relations & Corporate Communications (727) 532-8866 [email protected] Media: Brian Kosoy Director, Corporate Communications (727) 299-8865 [email protected]


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Instagram Outage Disrupts Thousands of U.S. Users
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



